Tuesday, September 19, 2017
Project co-funded by the European Commission in the framework of the 2nd Health Programme
Enter Title Minimize

SECTION F: SPECIFIC MUSCULOSKELETAL REQUIREMENTS

  • F.1 DONOR SCREENING
    • F.1.1. ACTIVITIES
      • F.1.1.1.Donor detection
      • F.1.1.2.Donor consent
      • F.1.1.3. Donor evaluation
        • F.1.1.3.1.General
        • F.1.1.3.2. Medical evaluation
          • F.1.3.3.2.1. Anamnesis
          • F.1.3.3.2.2. Social evaluation
          • F.1.3.3.2.3. Physical evaluation
          • F.1.3.3.2.4. Exclusion criteria
  • F.2. RECOVERY
    • F.2.1. ACTIVITIES
      • F.2.1.1. Access to the operating room or other recovery room
        • F.2.1.1.1. General
        • F.2.1.1.2. Deceased donors
          • F.2.1.1.2.1. Donor identification
          • F.2.1.1.2.2. Gowning
          • F.2.1.1.2.3. Donor preparation
          • F.2.1.1.2.4. Procurement of long bones of the lower limb
            • F.2.1.1.2.4.1. Procurement of the femur
            • F.2.1.1.2.4.2. Procurement of the tibia and the fibula
          • F.2.1.1.2.5. Procurement of the iliac crest or hemipelvis
          • F.2.1.1.2.6. Procurement of long bones of the upper limb
          • F.2.1.1.2.6.1. Procurement of the humerus
          • F.2.1.1.2.7. Procurement of the rib
          • F.2.1.1.2.8. Procurement of the fascia lata
          • F.2.1.1.2.9. Procurement of Achilles tendon
          • F.2.1.1.2.10. Procurement of the patellar tendon
          • F.2.1.1.2.10. Procurement of the menisci
          • F.2.1.1.2.11. Reconstruction of the donor’s body after procurement
        • F.2.1.2.3. Living donors
          • F.2.1.2.3.1. Living allogenic donors
            • F.2.1.2.3.1.1 Femoral head donors
          • F.2.1.2.3.2. Living autogenic donors
        • F.2.1.3. Processing during recovery
        • F.2.1.4. Quality control
        • F.2.1.5. Packaging and labelling
          • F.2.1.5.1. Primary packaging and labelling
            • F.2.1.5.1.1 Packaging for hypothermic storage
            • F.2.1.5.1.2. Packaging for cell culture
        • F.2.1.6. Storage and transport after recovery
          • F.2.1.6.1. Storage after tissue recovery
            • F.2.1.6.1.1. Storage temperatures
            • F.2.1.6.1.2. Storage time
              • F.2.1.6.1.2.1. Storage time for hypotermic storage
              • F.2.1.6.1.2.2. Storage time for cell culture
          • F.2.1.6.2.Transport after tissue recovery
        • F.2.1.7. Documentation and release for processing
  • F.3. PROCESSING
    • F.3.1. ACTIVITIE
      • F.3.1.1. Reception
      • F.3.1.2. Access to the processing facilitie
      • F.3.1.3. Processing
        • F.3.1.3.1.General
        • F.3.1.3.2. Processing methods
          • F.3.1.3.2.1. Processing of tissues and cells
          • F.3.1.3.2.2. Sterilisation or decontamination of musculoskeletal tissues and cells
      • F.3.1.4. Quality control
        • F.3.1.4.1. Microbiological control
          • F.3.1.4.1.1. General Principle
          • F.3.1.4.1.2. Methods
        • F.3.1.5. Packaging and labelling
        • F.3.1.6. Storage/ preservation
          • F.3.1.6.1. General
          • F.3.1.6.2. Methods of preservation and storage
            • F.3.1.6.2.1. Preservation and storage in hypotermic conditions
          • F.3.1.6.3. Storage area
        • F.3.1.7. Documentation and release
          • F.3.1.7.1. General
          • F.3.1.7.2. Release
            • F.3.1.7.2.1. Release of musculoskeletal tissue grafts
          • F.3.1.7.3. Processing file contents
          • F.3.1.7.4. Availability for inspection
          • F.3.1.7.5. Traceability
Print  
A3f Engine ::Terms Of Use::Privacy Statement